SBHIX: Saratoga Health & Biotechnology I

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

SBHIX Saratoga Health & Biotechnology I


Profile

SBHIX - Profile

Vitals

  • YTD Return -0.8%
  • 3 Yr Annualized Return -6.9%
  • 5 Yr Annualized Return -7.9%
  • Net Assets $12.8 M
  • Holdings in Top 10 45.2%

52 WEEK LOW AND HIGH

$23.05
$17.30
$24.03

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.82%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 32.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $250
  • IRA N/A

Fund Classification

  • Primary Caregory Uncategorized
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -0.8%
  • 3 Yr Annualized Total Return -6.9%
  • 5 Yr Annualized Total Return -7.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.02%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Saratoga Health & Biotechnology Fund
  • Fund Family Name
    Saratoga
  • Inception Date
    Jan 28, 2003
  • Shares Outstanding
    N/A
  • Share Class
    Inst
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Robert Stimpson

Fund Description

The fund will normally invest at least 80% of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value (or "market capitalization"). Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Performance

SBHIX - Performance

Return Ranking - Trailing

Period SBHIX Return Category Return Low Category Return High Rank in Category (%)
YTD -0.8% -3.8% 18.0% 95.35%
1 Yr 8.6% 1.3% 31.0% 90.48%
3 Yr -6.9%* -12.0% 21.9% 98.18%
5 Yr -7.9%* -11.7% 12.3% 97.09%
10 Yr 3.8%* -1.6% 16.7% 78.31%

* Annualized

Return Ranking - Calendar

Period SBHIX Return Category Return Low Category Return High Rank in Category (%)
2019 12.2% 5.7% 55.4% 91.38%
2018 -19.7% -25.3% 21.5% 94.55%
2017 -3.6% -10.8% 43.9% 92.59%
2016 -11.8% -31.6% 6.9% 29.52%
2015 -2.6% -20.4% 13.8% 57.00%

Total Return Ranking - Trailing

Period SBHIX Return Category Return Low Category Return High Rank in Category (%)
YTD -0.8% -3.8% 18.0% 95.35%
1 Yr 8.6% 1.3% 31.0% 90.48%
3 Yr -6.9%* -12.0% 25.0% 98.18%
5 Yr -7.9%* -11.7% 17.1% 97.09%
10 Yr 3.8%* -1.6% 19.1% 90.36%

* Annualized

Total Return Ranking - Calendar

Period SBHIX Return Category Return Low Category Return High Rank in Category (%)
2019 12.2% 5.7% 55.4% 91.38%
2018 -19.7% -25.3% 22.2% 94.55%
2017 -3.6% -10.8% 45.8% 95.37%
2016 -11.8% -26.4% 8.7% 44.76%
2015 -2.6% -16.6% 15.2% 70.00%

NAV & Total Return History


Holdings

SBHIX - Holdings

Concentration Analysis

SBHIX Category Low Category High SBHIX % Rank
Net Assets 12.8 M 2.28 M 49 B 88.81%
Number of Holdings 33 27 435 92.54%
Net Assets in Top 10 5.75 M 579 K 18.8 B 88.81%
Weighting of Top 10 45.19% 21.5% 76.0% 21.64%

Top 10 Holdings

  1. Gilead Sciences Inc 5.24%
  2. McKesson Corp 5.03%
  3. Amgen Inc 4.98%
  4. Cigna Corp 4.89%
  5. Biogen Inc 4.84%
  6. GlaxoSmithKline PLC ADR 4.83%
  7. Charles River Laboratories International Inc 4.04%
  8. Novartis AG ADR 3.98%
  9. Pfizer Inc 3.70%
  10. Novo Nordisk A/S ADR 3.67%

Asset Allocation

Weighting Return Low Return High SBHIX % Rank
Stocks
97.31% 65.31% 100.23% 55.97%
Cash
2.69% -0.23% 34.69% 29.85%
Preferred Stocks
0.00% 0.00% 4.57% 38.81%
Other
0.00% -1.66% 9.19% 52.99%
Convertible Bonds
0.00% 0.00% 0.00% 27.61%
Bonds
0.00% 0.00% 16.54% 32.09%

Stock Sector Breakdown

Weighting Return Low Return High SBHIX % Rank
Healthcare
100.00% 60.00% 100.00% 11.94%
Utilities
0.00% 0.00% 0.00% 27.61%
Technology
0.00% 0.00% 15.32% 37.31%
Real Estate
0.00% 0.00% 5.63% 34.33%
Industrials
0.00% 0.00% 3.92% 32.09%
Financial Services
0.00% 0.00% 1.55% 45.52%
Energy
0.00% 0.00% 0.33% 28.36%
Communication Services
0.00% 0.00% 5.13% 31.34%
Consumer Defense
0.00% 0.00% 36.48% 35.07%
Consumer Cyclical
0.00% 0.00% 0.96% 31.34%
Basic Materials
0.00% 0.00% 2.52% 41.79%

Stock Geographic Breakdown

Weighting Return Low Return High SBHIX % Rank
US
77.99% 53.12% 99.27% 50.00%
Non US
19.32% 0.00% 45.40% 43.28%

Expenses

SBHIX - Expenses

Operational Fees

SBHIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.82% 0.10% 25.14% 31.06%
Management Fee 1.25% 0.00% 1.25% 96.27%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee 0.15% 0.03% 0.40% 60.47%

Sales Fees

SBHIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

SBHIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% 16.67%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SBHIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 32.00% 0.70% 248.00% 28.46%

Distributions

SBHIX - Distributions

Dividend Yield Analysis

SBHIX Category Low Category High SBHIX % Rank
Dividend Yield 0.00% 0.00% 0.06% 29.10%

Dividend Distribution Analysis

SBHIX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Annually

Net Income Ratio Analysis

SBHIX Category Low Category High SBHIX % Rank
Net Income Ratio -0.02% -2.53% 2.12% 44.36%

Capital Gain Distribution Analysis

SBHIX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

SBHIX - Fund Manager Analysis

Managers

Robert Stimpson


Start Date

Tenure

Tenure Rank

Jan 18, 2019

1.53

1.5%

Robert D. Stimpson, CFA, CMT. Mr. Stimpson is Co-Chief Investment Officer and a Portfolio Manager at Oak Associates, which he joined in 2001. Prior to joining Oak Associates in 2001, Mr. Stimpson earned an MBA from Emory University. Previously, Mr. Stimpson worked as an Equity Market Analyst for I.D.E.A., ltd and for Merrill Lynch as a Financial Consultant. He has been with the investment industry since 1997. In addition to the CFA designation, Mr. Stimpson holds the CMT charter from the Market Technicians Association.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.16 22.89 8.72 20.26